Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
Example Bundle: IPS Example 2
id:
gravitate-ips-2
Composition status:
final
Composition Type:
Patient summary Document
Subject:
identifier:
ips-2
Name:
IPS-2 Gravitate
active:
true
gender:
female
Birth Date:
1946-05-05
Sections
Medication Summary
Medication:
trastuzumab
status:
active
Medication Detail:
-
System
http://example.org/mpid/no
Code:
4249 []
Dose Form:
Powder and solvent for concentrate for solution for infusion
Ingredient:
trastuzumab (http://fdasis.nlm.nih.gov#P188ANX8CK)
Route:
Intravenous use
Medication:
simvastatin
status:
active
Medication Detail:
-
System
https://www.who-umc.org/phpid
Code:
F92168108C432D63DACDD70444176BB3 [Lipcut Simvastatin 20 mg tablet]
Dose Form:
Tablet
Ingredient:
SIMVASTATIN (http://fdasis.nlm.nih.gov#AGG2FN16EV)
Route:
Oral use
Medication:
enbrel
status:
active
Medication Detail:
-
System
https://www.who-umc.org/phpid
Code:
0xF79CABF272B6A7EEF104DDDA44E82716 [Enbrel Etanercept 25 mg powder for solution for injection]
Dose Form:
Powder and solution for solution for injection
Ingredient:
ETANERCEPT (ENBREL) (http://fdasis.nlm.nih.gov#OP401G7OJC)
Route:
Subcutaneous use
Medication:
carbamazepine
status:
active
Medication Detail:
-
System
https://www.who-umc.org/phpid
Code:
5C62673C79E096D37914D32A45AA8F4D [Tegretol Carbamazepine 200 mg tablets]
-
System
https://www.who-umc.org/phpid
Code:
FB9808F4FED210183F412F9998622287 [Tegretol Carbamazepine 200 mg tablets]
Dose Form:
Tablet
Ingredient:
CARBAMAZEPINE (http://fdasis.nlm.nih.gov#33CM23913M)
Route:
Oral use
Allergies and Intolerances
Allergy:
(no-allergy-info)
clinicalStatus:
active
verificationStatus:
confirmed
Problem List
Condition:
Malignant neoplasm of breast (254837009)
clinicalStatus:
active
asserter:
Dr. IPS2
Condition:
Rheumatoid arthritis (69896004)
clinicalStatus:
active
asserter:
Dr. IPS2
onsetDateTime:
2015
Condition:
Hypercholesterolemia (13644009)
clinicalStatus:
active
onsetDateTime:
1993
Condition:
Epilepsy (84757009)
clinicalStatus:
active
onsetDateTime:
1993
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
